UNSPSC 51101649: Clopidol

This classification denotes an antiprotozoal agent with the molecular formula C7H7Cl2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8J763HFF5N, chemically known as 3,5-dichloro-4-hydroxy-2,6-dimethylpyridine but generally known as clopidol, which bears US NIH Compound Identifier 18087. European Medicines Agency schedules Clopidol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06739MIG.

UNSPSC 51101649 Clopidol is a Commodity code that nominally covers a specific antiprotozoal feed additive, yet recent state and local solicitation activity shows little alignment with this narrowly defined pharmaceutical product. The recent opportunities posted under this code involve procurement of distinct pharmaceutical products and medical supplies—specifically naloxone for overdose reversal and drug deactivation systems for community health programs, neither of which is clopidol. State and local health departments and county public health agencies are the primary issuing bodies, reflecting demand from health-focused jurisdictions rather than agricultural or veterinary buyers who would typically purchase feed additives. The mismatch between the code's nominal scope and the actual goods being solicited suggests either miscoding in the source data or a state/local classification practice that does not align tightly with the UNSPSC definition.

Activity is geographically dispersed, with recent opportunities originating in Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse cooperative purchasing consortium, valued at $2,999,999.11 over 12 months plus two renewal years—an IFB process in which Chartwell was selected as the lowest responsive and responsible bidder. Seminole County, Florida posted an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, response deadline July 26, 2023 (note: the deadline date appears outdated relative to the posting date). Neither recent opportunity directly reflects clopidol procurement; prospectors should verify whether this code is actively used for its intended product or consider whether the source data reflects miscoding.